PT - JOURNAL ARTICLE AU - Ghosh, Sujoy AU - Roy, Saikat Sinha TI - Global-scale analysis and longitudinal assessment of COVID-19 incidence in the first six months AID - 10.1101/2021.03.31.21254739 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.31.21254739 4099 - http://medrxiv.org/content/early/2021/04/06/2021.03.31.21254739.short 4100 - http://medrxiv.org/content/early/2021/04/06/2021.03.31.21254739.full AB - Studies examining factors responsible for COVID-19 incidence have mostly focused at the national or sub-national level. Here we undertake an analysis of COVID-19 cases at the global scale to identify key factors associated with disease incidence. A regression modeling framework was used to identify key variables associated with COVID-19 incidence, and to assess longitudinal trends in reported incidence at the country-level. New COVID-19 case dynamics in response to lockdowns was characterized via cluster analysis. Eleven variables were found to be independently associated with COVID-19 infections (p<1e-05) and a 4-variable model adequately explained global variations in COVID-19 cases (p<0.01). COVID-19 case trajectories for most countries followed the log-logistic curve. Six predominant country clusters summarized the differences in individual country’s response to lockdowns. Globally, economic and meteorological factors are important determinants of COVID-19 incidence. Analysis of longitudinal trends and lockdown effects on COVID-19 caseloads further highlights important nuances in country-specific responses to the pandemic. These findings on the first six months of the pandemic has important implications for additional phases of the disease currently underway in many countries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by the National Medical Research Council and Ministry of Health, Singapore.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript is publicly available. It can also be obtained by sending an email to sujoy.ghosh@duke-nus.edu.sg